The epidemiology of Parkinson's disease: risk factors and prevention

被引:1333
作者
Ascherio, Alberto [1 ,2 ,3 ]
Schwarzschild, Michael A. [4 ]
机构
[1] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol & Nutr, Boston, MA USA
[2] Brigham & Womens Hosp, Channing Lab, Dept Med, 75 Francis St, Boston, MA 02115 USA
[3] Harvard Med Sch, Boston, MA USA
[4] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
基金
美国国家卫生研究院;
关键词
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; URIC-ACID LEVELS; CALCIUM-CHANNEL BLOCKERS; BODY-MASS INDEX; LIPID-LOWERING DRUGS; PHYSICAL-ACTIVITY; PLASMA URATE; COFFEE CONSUMPTION; CAFFEINE INTAKE; STATIN USE;
D O I
10.1016/S1474-4422(16)30230-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Since 2006, several longitudinal studies have assessed environmental or behavioural factors that seem to modify the risk of developing Parkinson's disease. Increased risk of Parkinson's disease has been associated with exposure to pesticides, consumption of dairy products, history of melanoma, and traumatic brain injury, whereas a reduced risk has been reported in association with smoking, caffeine consumption, higher serum urate concentrations, physical activity, and use of ibuprofen and other common medications. Randomised trials are investigating the possibility that some of the negative risk factors might be neuroprotective and thus beneficial in individuals with early Parkinson's disease, particularly with respect to smoking (nicotine), caffeine, and urate. In the future, it might be possible to identify Parkinson's disease in its prodromal phase and to promote neuroprotective interventions before the onset of motor symptoms. At this time, however, the only intervention that seems justifiable for the primary prevention of Parkinson's disease is the promotion of physical activity, which is likely to be beneficial for the prevention of several chronic diseases.
引用
收藏
页码:1255 / 1270
页数:16
相关论文
共 239 条
[1]   Midlife adiposity and the future risk of Parkinson's disease [J].
Abbott, RD ;
Ross, GW ;
White, LR ;
Nelson, JS ;
Masaki, KH ;
Tanner, CM ;
Curb, JD ;
Blanchette, PL ;
Popper, JS ;
Petrovitch, H .
NEUROLOGY, 2002, 59 (07) :1051-1057
[2]   Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia Aging Study [J].
Abbott, RD ;
Ross, GW ;
White, LR ;
Sanderson, WT ;
Burchfiel, CM ;
Kashon, M ;
Sharp, DS ;
Masaki, KH ;
Curb, JD ;
Petrovitch, H .
JOURNAL OF NEUROLOGY, 2003, 250 (Suppl 3) :30-39
[3]   Midlife milk consumption and substantia nigra neuron density at death [J].
Abbott, Robert D. ;
Ross, G. Webster ;
Petrovitch, Helen ;
Masaki, Kamal H. ;
Launer, Lenore J. ;
Nelson, James S. ;
White, Lon R. ;
Tanner, Caroline M. .
NEUROLOGY, 2016, 86 (06) :512-519
[4]   Gout and risk of Parkinson disease -: A prospective study [J].
Alonso, Alvaro ;
Garcia Rodriguez, Luis A. ;
Logroscino, Giancarlo ;
Hernan, Miguel A. .
NEUROLOGY, 2007, 69 (17) :1696-1700
[5]  
[Anonymous], 2006, NEUROLOGY, DOI DOI 10.1212/01.WNL.0000234884.42413.BC
[6]   Nonsteroidal anti-inflammatory drugs in experimental parkinsonian models and Parkinson's disease [J].
Asanuma, Masato ;
Miyazaki, Ikuko .
CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (14) :1428-1434
[7]   Common anti-inflammatory drugs are potentially therapeutic for Parkinson's disease? [J].
Asanuma, Masato ;
Miyazaki, Ikuko .
EXPERIMENTAL NEUROLOGY, 2007, 206 (02) :172-178
[8]   Coffee consumption, gender, and Parkinson's disease mortality in the Cancer Prevention Study II cohort: The modifying effects of estrogen [J].
Ascherio, A ;
Weisskopf, MG ;
O'Reilly, EJ ;
McCullough, ML ;
Calle, EE ;
Rodriguez, C ;
Thun, MJ .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 160 (10) :977-984
[9]   Caffeine, postmenopausal estrogen, and risk of Parkinson's disease [J].
Ascherio, A ;
Chen, H ;
Schwarzschild, MA ;
Zhang, SM ;
Colditz, GA ;
Speizer, FE .
NEUROLOGY, 2003, 60 (05) :790-795
[10]   Prospective study of caffeine consumption and risk of Parkinson's disease in men and women [J].
Ascherio, A ;
Zhang, SMM ;
Hernán, MA ;
Kawachi, I ;
Colditz, GA ;
Speizer, FE ;
Willett, WC .
ANNALS OF NEUROLOGY, 2001, 50 (01) :56-63